Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


17.09.2018

1 Am J Surg Pathol
1 Biochem Biophys Res Commun
5 Blood
1 BMC Cancer
4 Br J Haematol
1 Cancer
1 Curr Treat Options Oncol
1 Haematologica
2 Mod Pathol
1 Neurology
2 Oncology (Williston Park)


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg Pathol

  1. CHEN BJ, Ruminy P, Roth CG, Bisig B, et al
    Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease.
    Am J Surg Pathol. 2018 Sep 11. doi: 10.1097/PAS.0000000000001154.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. LU L, Fu X, Li Z, Qiu Y, et al
    Platelet-derived growth factor receptor alpha (PDGFRalpha) is overexpressed in NK/T-cell lymphoma and mediates cell survival.
    Biochem Biophys Res Commun. 2018 Sep 7. pii: S0006-291X(18)31869.
    PubMed     Text format     Abstract available


    Blood

  3. SUD A, Thomsen H, Orlando G, Forsti A, et al
    Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma.
    Blood. 2018 Sep 7. pii: blood-2018-06-855296. doi: 10.1182/blood-2018-06-855296.
    PubMed     Text format     Abstract available

  4. KAMIJO H, Miyagaki T, Shishido-Takahashi N, Nakajima R, et al
    Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma.
    Blood. 2018 Sep 7. pii: blood-2018-04-845834. doi: 10.1182/blood-2018-04-845834.
    PubMed     Text format     Abstract available

  5. MEHTA-SHAH N, Clemens MW, Horwitz SM
    How I treat breast implant-associated anaplastic large cell lymphoma.
    Blood. 2018 Sep 12. pii: blood-2018-03-785972. doi: 10.1182/blood-2018-03-785972
    PubMed     Text format     Abstract available

  6. LI L, Zhang J, Chen J, Xu-Monette ZY, et al
    B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.
    Blood. 2018 Sep 12. pii: blood-2018-03-841015. doi: 10.1182/blood-2018-03-841015
    PubMed     Text format     Abstract available

  7. MUSILOVA K, Devan J, Cerna K, Seda V, et al
    miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels.
    Blood. 2018 Sep 13. pii: blood-2018-06-855502. doi: 10.1182/blood-2018-06-855502
    PubMed     Text format     Abstract available


    BMC Cancer

  8. STARREVELD DEJ, Daniels LA, Valdimarsdottir HB, Redd WH, et al
    Light therapy as a treatment of cancer-related fatigue in (non-)Hodgkin lymphoma survivors (SPARKLE trial): study protocol of a multicenter randomized controlled trial.
    BMC Cancer. 2018;18:880.
    PubMed     Text format     Abstract available


    Br J Haematol

  9. BRANDEFORS L, Melin B, Lindh J, Lundqvist K, et al
    Prognostic factors and primary treatment for Waldenstrom macroglobulinemia - a Swedish Lymphoma Registry study.
    Br J Haematol. 2018 Sep 10. doi: 10.1111/bjh.15558.
    PubMed     Text format     Abstract available

  10. JIANG C, Bi C, Jiang X, Tian T, et al
    The miR-17~92 cluster activates mTORC1 in mantle cell lymphoma by targeting multiple regulators in the STK11/AMPK/TSC/mTOR pathway.
    Br J Haematol. 2018 Sep 10. doi: 10.1111/bjh.15591.
    PubMed     Text format    

  11. CENCINI E, Sicuranza A, Fabbri A, Ferrigno I, et al
    Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab.
    Br J Haematol. 2018 Sep 11. doi: 10.1111/bjh.15582.
    PubMed     Text format     Abstract available

  12. FAULK KE, Sopfe JM, Campbell K, Liptzin DR, et al
    Pulmonary toxicity in paediatric patients with relapsed or refractory Hodgkin lymphoma receiving brentuximab vedotin.
    Br J Haematol. 2018 Sep 10. doi: 10.1111/bjh.15586.
    PubMed     Text format     Abstract available


    Cancer

  13. HUNTINGTON SF, Hoag JR, Zhu W, Wang R, et al
    Oncologist Volume and Outcomes in Older Adults Diagnosed With Diffuse Large B Cell Lymphoma.
    Cancer. 2018 Sep 14. doi: 10.1002/cncr.31688.
    PubMed     Text format     Abstract available


    Curr Treat Options Oncol

  14. KANSARA R
    Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma.
    Curr Treat Options Oncol. 2018;19:52.
    PubMed     Text format     Abstract available


    Haematologica

  15. SCHUHMACHER B, Bein J, Rausch T, Benes V, et al
    JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte rich large B-cell lymphoma.
    Haematologica. 2018 Sep 13. pii: haematol.2018.203224.
    PubMed     Text format     Abstract available


    Mod Pathol

  16. DI NAPOLI A, De Cecco L, Piccaluga PP, Navari M, et al
    Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas.
    Mod Pathol. 2018 Sep 11. pii: 10.1038/s41379-018-0130.
    PubMed     Text format     Abstract available

  17. QUESADA AE, Medeiros LJ, Clemens MW, Ferrufino-Schmidt MC, et al
    Breast implant-associated anaplastic large cell lymphoma: a review.
    Mod Pathol. 2018 Sep 11. pii: 10.1038/s41379-018-0134.
    PubMed     Text format     Abstract available


    Neurology

  18. TOYOTA T, Sennari Y, Okada K, Kawahara A, et al
    Myoclonia continua in primary CNS natural killer/T-cell lymphoma, nasal type.
    Neurology. 2016 Dec 7. pii: 10.1212/WNL.0000000000003515.
    PubMed     Text format    


    Oncology (Williston Park)

  19. HALL KH, Panjic EH, Valla K, Flowers CR, et al
    How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis.
    Oncology (Williston Park). 2018;32:303-9.
    PubMed     Text format     Abstract available

  20. PERAZELLA MA, Rosner MH
    Acute Kidney Injury in Patients With Cancer.
    Oncology (Williston Park). 2018;32:351-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: